Liquid Biopsy Market is expected to be a major factor fueling the global industry growth by 2028
Liquid Biopsy Industry Overview The global liquid biopsy market size is expected to reach USD 19.35 billion by 2028, registering a CAGR of 13.5% during the forecast period, according to a new report by Grand View Research, Inc. It is a revolutionary technique that has created various opportunities that were previously unexplored. Liquid Biopsy Market Segmentation Grand View Research has segmented the global liquid biopsy market on the basis of sample type, biomarker, technology, and region: Based on the Sample Type Insights, the market is segmented into Blood Sample Based and Others. Blood sample-based tests dominated the market with a revenue share of over 69%. A blood-based test is non-invasive, has no risk, and is painless. In addition, it reduces the cost and time taken for diagnosis. CTCs, cfDNAs, and exosomes, as well as microvesicles, can be detected in the blood sample, thus increasing the adoption of blood-based liquid biopsy. The circu...